Group 1 - The core viewpoint of the news is the performance and holdings of the Huatai Fuhua Medical Active Growth One-Year Holding Mixed Fund A, which has shown significant growth in various time frames [1] - As of June 30, 2025, the fund's net value is 0.8287 yuan, with a growth of 1.78% [1] - The fund has achieved a return of 4.71% over the past month, 51.75% over the past six months, and 67.08% year-to-date, ranking 4497 out of 4701, 93 out of 4538, and 117 out of 4492 respectively [1] Group 2 - The top ten stock holdings of the fund account for a total of 61.79%, with significant positions in companies such as Sanofi (10.07%), Innovent Biologics (8.94%), and Kelun-Biotech (8.71%) [1] - The fund was established on August 21, 2020, and has a total scale of 1.922 billion yuan as of June 30, 2025 [1] - The fund manager is Zheng Lei, who has extensive experience in the medical and healthcare investment sector [2]
8月21日汇添富医疗积极成长一年持有混合A净值增长1.78%，今年来累计上涨67.08%
Sou Hu Cai Jing·2025-08-21 12:01